What is ameloblastic carcinoma?
Ameloblastic carcinoma is a rare cancer of the jaw that arises from the tissues that form teeth. These are called odontogenic tissues, and tumours that grow from them are called odontogenic tumours. Most odontogenic tumours are benign, but ameloblastic carcinoma is malignant: it can destroy bone, come back after treatment and, in some people, spread to other parts of the body.
It is the most frequent of the malignant odontogenic tumours, making up roughly three in ten of them (Robinson et al., 2024). Even so, it is very uncommon, and much of what is known comes from case reports and small series.
The tumour looks partly like an ameloblastoma, a benign but locally aggressive jaw tumour, but its cells show features of cancer. It may arise on its own (primary) or develop within an existing ameloblastoma (secondary).
Ameloblastic carcinoma usually affects adults in middle age, with an average age of about 45 in published reviews (Deng et al., 2019). The lower jaw (mandible) is affected more often than the upper jaw. Treatment is mainly surgery with wide margins, sometimes followed by radiotherapy.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of cancer | Malignant odontogenic (tooth-forming tissue) epithelial tumour |
| How common | Very rare; a few hundred cases reported |
| Typical age | Average mid-40s; wide range from children to older adults |
| Sex | Reports differ; several series show more men |
| Main site | Lower jaw, especially the back; upper jaw less often |
| Spread | Mainly local; lungs are the commonest distant site |
| Main treatment | Wide surgical removal of the affected jaw |
| Outlook | Variable; recurrence is common and late spread can occur |
2. Types of ameloblastic carcinoma
| Type | Description |
|---|---|
| Primary | Arises as a cancer from the start |
| Secondary (intraosseous) | Develops within a pre-existing ameloblastoma inside the bone |
| Secondary (peripheral) | Develops from an ameloblastoma in the gum, outside the bone |
In a review of 153 cases, whether the tumour was primary or secondary did not appear to change survival (Saluja and Hosalkar, 2018).
How it differs from related tumours
| Feature | Ameloblastoma | Ameloblastic carcinoma | Metastasising ameloblastoma |
|---|---|---|---|
| Cells | Benign-looking | Show cancer features | Benign-looking |
| Growth | Slow, locally aggressive | Faster, more destructive | Slow |
| Spread | Does not spread | Can spread to lungs and lymph nodes | Spreads despite benign cells |
| Treatment | Surgery | Wider surgery, possible radiotherapy | Surgery for each site |
Where these tumours come from
Teeth develop from a special layer of cells in the jaw. The ameloblasts in this layer make enamel, the hard outer coating of the tooth. After the teeth have formed, small groups of these cells can remain trapped in the jaw bone or gum for life.
| Term | Meaning |
|---|---|
| Odontogenic | Arising from tissues that form teeth |
| Ameloblast | A cell that makes tooth enamel |
| Epithelial | Made of lining-type cells rather than connective tissue |
| Intraosseous | Inside the bone |
| Peripheral | In the soft gum tissue, outside the bone |
Ameloblastic carcinoma is thought to grow from these leftover tooth-forming cells, which is why it occurs almost only in the jaws.
3. Causes and risk factors
The cause is not known. Some ameloblastic carcinomas share gene changes with ameloblastoma, such as BRAF V600E mutations, and others carry additional changes linked to more aggressive behaviour.
| Factor | Notes |
|---|---|
| Existing ameloblastoma | Especially if it has recurred many times or been present for years |
| Previous radiotherapy to the jaw | Possible link in a few secondary cases |
| Middle age | Most cases occur between 30 and 60 |
| Lifestyle factors | No clear link with smoking or alcohol |
| Inherited conditions | None known |
4. How does it look
In the mouth and face
| Feature | Description |
|---|---|
| Swelling | A firm, enlarging swelling of the jaw or gum |
| Surface | The gum may be normal, red or ulcerated |
| Teeth | Loose or displaced teeth |
| Face | Visible asymmetry when the tumour is large |
| Pain | Present in about half of people |
On X-rays and scans
| Feature | Description |
|---|---|
| Pattern | A dark (radiolucent) area in the jaw, single or with several compartments |
| Borders | Often ragged and ill-defined; some are well-defined |
| Bone | Thinning or breaking through the outer layer of bone |
| Teeth | Root resorption or displacement |
| Soft tissue | Growth into the surrounding tissues on CT or MRI |
In the large review by Robinson and colleagues, just over half of tumours had poorly defined borders, but a substantial minority looked well-defined and single-chambered, which can make them resemble benign cysts (Robinson et al., 2024).
Under the microscope
| Feature | Description |
|---|---|
| Basic pattern | Islands of cells resembling ameloblastoma |
| Cancer features | Enlarged, irregular nuclei, many dividing cells |
| Necrosis | Areas of dead tumour tissue |
| Invasion | Growth into bone, nerves or blood vessels |
| Ki-67 | A high proliferation index in many cases |
5. Symptoms
Common symptoms
- A swelling of the jaw, often growing over months
- Pain or tenderness in the jaw
- Loose teeth or teeth moving out of position
- Dentures that no longer fit
Less common symptoms
| Symptom | What it may mean |
|---|---|
| Numbness of the lip or chin | Pressure on or invasion of the nerve in the lower jaw |
| A sore or ulcer on the gum | Tumour breaking through the surface |
| Difficulty opening the mouth | Spread into the chewing muscles |
| Nasal blockage or bleeding | Upper jaw tumours growing into the sinus |
| Breathlessness or cough | Rarely, spread to the lungs |
When to seek medical advice
See a dentist or doctor if you have a swelling of the jaw, loose teeth without gum disease, numbness of the lip or chin, or a jaw lump that keeps growing. Most jaw swellings are not cancer, but these signs should be investigated.
6. Diagnosis
| Test | Purpose |
|---|---|
| Dental and mouth examination | Assesses the swelling and teeth |
| Panoramic X-ray (OPG) | First view of the jaw |
| CT scan | Shows bone destruction and extent |
| MRI | Shows soft-tissue and nerve involvement |
| Biopsy | Confirms the diagnosis; review by a head and neck pathologist |
| Chest CT | Checks for lung spread |
| PET-CT | In selected cases, to look for distant spread |
Conditions that can look similar
| Condition | Notes |
|---|---|
| Ameloblastoma | Benign; cells lack cancer features |
| Odontogenic cysts | Benign fluid-filled cavities |
| Squamous cell carcinoma of the mouth | Usually starts on the surface lining |
| Other odontogenic cancers | Such as clear cell odontogenic carcinoma |
| Metastasis from another cancer | Spread to the jaw from elsewhere |
Staging
There is no staging system specific to ameloblastic carcinoma. Many teams use the TNM system for oral cavity cancer to describe tumour size, lymph node involvement and distant spread.
7. Treatment
Treatment is planned by a head and neck cancer team, including maxillofacial surgeons, reconstructive surgeons, oncologists, dentists and speech and swallowing therapists.
Surgery
| Procedure | What it involves |
|---|---|
| Segmental mandibulectomy | Removal of a full-thickness section of the lower jaw |
| Maxillectomy | Removal of part of the upper jaw |
| Wide margins | Healthy bone and tissue, often 1-2 cm, removed around the tumour |
| Neck dissection | If lymph nodes are involved |
| Reconstruction | Often with bone from the leg (fibula flap) or hip, sometimes with dental implants later |
Simple scraping out (curettage) or local removal is associated with more recurrences, so wide resection is preferred. A review found that early surgery was linked to the best survival (Saluja and Hosalkar, 2018).
Jaw reconstruction explained
| Option | Description |
|---|---|
| Fibula free flap | A section of the lower leg bone, with its blood supply, is shaped to replace the jaw |
| Hip (iliac crest) flap | Bone from the hip, useful for some jaw shapes |
| Titanium plate | Bridges the gap, sometimes as a temporary measure |
| Obturator | A removable plate that fills a gap in the upper jaw and palate |
| Virtual surgical planning | 3D scans used before surgery to plan cuts and shape the new jaw |
Modern reconstruction aims to restore chewing, speech, swallowing and facial shape. Most people walk normally after a fibula flap, although the leg can feel weak or stiff for some weeks.
Radiotherapy
| Situation | Role |
|---|---|
| Positive or close margins | To lower the risk of recurrence |
| Tumours that cannot be removed | For local control |
| Spread to lymph nodes | After neck surgery |
| Painful metastases | For symptom relief |
Drug treatment
Chemotherapy has a limited, uncertain role and is mainly used for widespread disease. For tumours with a BRAF V600E mutation, BRAF-targeted drugs have been tried in individual patients.
Side effects
| Treatment | Possible side effects |
|---|---|
| Jaw surgery | Change in facial shape, numbness, difficulty chewing or speaking |
| Reconstruction | Healing problems at the donor site, such as the leg |
| Radiotherapy | Dry mouth, sore mouth, taste changes, risk of jaw bone damage (osteoradionecrosis) |
What treatment involves day to day
| Stage | What to expect |
|---|---|
| Before surgery | Dental assessment; damaged teeth may be removed |
| Hospital stay | Often 1-2 weeks after jaw resection and reconstruction |
| Eating | Soft or liquid diet at first, sometimes a feeding tube for a short time |
| Rehabilitation | Speech and swallowing therapy, jaw exercises |
| Dental rehabilitation | Implants or prostheses months later |
8. Outlook (prognosis)
The outlook varies. Many people are cured by complete surgery, but recurrence is common, and the risk of recurrence keeps rising over many years of follow-up, while survival falls gradually (Robinson et al., 2024).
In a pooled analysis of 143 cases, recurrences were recorded in about a quarter and metastases in nearly a fifth (Deng et al., 2019).
| Factor | Effect on outlook |
|---|---|
| Complete removal with clear margins | Better outcome |
| Older age | Poorer survival |
| Upper jaw site | May be harder to remove completely |
| Distant spread | Poorer outlook |
| Conservative surgery | Higher risk of recurrence |
9. Follow-up
| Follow-up | Purpose |
|---|---|
| Clinic review every 1-3 months at first | Checks the mouth, jaw and neck |
| CT or MRI of the jaw | Looks for recurrence |
| Chest CT | Looks for lung spread |
| Dental care | Regular checks, especially after radiotherapy |
| Long-term follow-up | Lifelong, because recurrence and spread can appear late |
10. Living with ameloblastic carcinoma
- See your dentist regularly and keep your mouth clean
- Do jaw-stretching exercises as advised to prevent stiffness
- Ask for dietitian support if eating is difficult
- Avoid tooth extractions after radiotherapy without discussing it with your team
- Report new swelling, pain, numbness or cough
- Avoid smoking, which slows healing and harms reconstructed tissue
- Keep a record of your scans and pathology, as follow-up may continue for many years
- Tell your team about leg pain or stiffness after a fibula flap
- Seek support for changes in appearance or speech from head and neck cancer groups
11. Frequently asked questions
| Question | Answer |
|---|---|
| Is it the same as ameloblastoma? | No; ameloblastoma is benign, while ameloblastic carcinoma is a cancer |
| Is it a mouth cancer? | It is a jaw bone cancer arising from tooth-forming tissue |
| Will I lose part of my jaw? | Often, yes; reconstruction can restore shape and function |
| Can I have teeth afterwards? | Dental implants or dentures are often possible later |
| Is it inherited? | No |
| Who should treat it? | A specialist head and neck or maxillofacial cancer team with experience of jaw tumours |
| Can it spread? | Yes, most often to the lungs |
| Will I need radiotherapy? | Only in some cases, such as close margins |
| How long is recovery after jaw surgery? | Usually several weeks in hospital and at home, then months of rehabilitation |
| Will my face look different? | There may be some change, but reconstruction aims to keep it as natural as possible |
12. Questions to ask your care team
- Is my tumour primary or secondary?
- How much of my jaw will need to be removed?
- What reconstruction do you recommend?
- Were the margins clear?
- Do I need radiotherapy?
- Does my tumour have a BRAF mutation?
- How often will I need scans?
- Will I need dental work before treatment starts?
- Who can help me with eating and speech afterwards?
Resources
- Deng, L. et al. (2019) ‘Ameloblastic carcinoma: clinicopathological analysis of 18 cases and a systematic review’, Head and Neck, 41(12), pp. 4191-4198.
- Robinson, L. et al. (2024) ‘Ameloblastic carcinoma: a systematic review’, Journal of Oral Pathology and Medicine, 53(3), pp. 174-181.
- Saluja, T.S. and Hosalkar, R. (2018) ‘Reconnoitre ameloblastic carcinoma: a prognostic update’, Oral Oncology, 77, pp. 118-124.
- National Cancer Institute (2026) Lip and Oral Cavity Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/head-and-neck/hp/adult/lip-mouth-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.